Jonathan Mitchell

ORCID: 0000-0003-3792-4058
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Emotions and Moral Behavior
  • SARS-CoV-2 and COVID-19 Research
  • Tryptophan and brain disorders
  • Genetic Associations and Epidemiology
  • Nanoplatforms for cancer theranostics
  • Monoclonal and Polyclonal Antibodies Research
  • Mental Health and Psychiatry
  • Prostate Cancer Treatment and Research
  • Acute Myeloid Leukemia Research
  • Glioma Diagnosis and Treatment
  • Immune cells in cancer
  • Adenosine and Purinergic Signaling
  • Genomics and Rare Diseases
  • Advanced Neural Network Applications
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Phagocytosis and Immune Regulation
  • Domain Adaptation and Few-Shot Learning
  • Cancer-related gene regulation
  • Cancer, Stress, Anesthesia, and Immune Response
  • Phenomenology and Existential Philosophy
  • Video Surveillance and Tracking Methods
  • Psychotherapy Techniques and Applications
  • Bacterial Infections and Vaccines
  • Complement system in diseases
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Promega (United States)
2021-2025

University of Miami
2023-2025

AstraZeneca (United Kingdom)
2025

AstraZeneca (Brazil)
2022-2024

University of Michigan
2024

Sylvester Comprehensive Cancer Center
2024

Cleveland Clinic
2024

Cleveland Clinic Lerner College of Medicine
2024

Johns Hopkins University
2022

Johns Hopkins Medicine
2022

Dravet syndrome is an archetypal rare severe epilepsy, considered 'monogenic', typically caused by loss-of-function SCN1A variants. Despite a recognizable core phenotype, its marked phenotypic heterogeneity incompletely explained differences in the causal variant or clinical factors. In 34 adults with SCN1A-related syndrome, we show additional genomic variation beyond contributes to phenotype and diversity, excess of variants epilepsy-related genes as set examples blended phenotypes,...

10.1093/brain/awad111 article EN cc-by Brain 2023-04-03
Annalisa Vetro Cristiana Pelorosso Simona Balestrini Alessio Masi Sophie Hambleton and 95 more Emanuela Argilli Valerio Conti Simone Giubbolini Rebekah Barrick Gaber Bergant Karin Writzl Emilia K. Bijlsma Theresa Brunet Pilar Cacheiro Davide Mei Anita Devlin Mariëtte J.V. Hoffer Keren Machol Guido Mannaioni Masamune Sakamoto Manoj P. Menezes Thomas Courtin Elliott H. Sherr Riccardo Parra Ruth Richardson Tony Roscioli Marcello Scala Celina von Stülpnagel Damian Smedley Francesca Pochiero Francesco Mari Venkateswaran Ramesh Valeria Capra Maria Margherita Mancardi Boris Keren C. Mignot Matteo Lulli Kendall C. Parks Helen Griffin Melanie Brugger Vincenzo Nigro Mitsuhiro Kato Reiko Koichihara Borut Peterlin Mitsuhiro Kato Ryuto Maki Yohei Nitta John C. Ambrose Prabhu Arumugam R. Bevers Marta Bleda F. Boardman-Pretty C. R. Boustred Helen Brittain Matthew A. Brown Mark J. Caulfield G. C. Chan Adam Giess John N. Griffin Angela Hamblin Bingyang Shi Tim Hubbard Robert B. Jackson Louise J. Jones Dalia Kasperavičiūtė Melis Kayikci Athanasios Kousathanas L. Lahnstein Anna Lakey S. E. A. Leigh I. U. S. Leong Javier Ferreiros F. Maleady-Crowe Meriel McEntagart Federico Minneci Jonathan Mitchell Loukas Moutsianas Michael P. Mueller Nirupa Murugaesu Anna C. Need Peter O’Donovan Chris A. Odhams Christine Patch D. Perez-Gil Monica Pereira J. Pullinger T. Rahim Augusto Rendon Tim Rogers K. Savage Kushmita Sawant Richard H. Scott Afshan Siddiq A. Sieghart Samuel C. Smith Alona Sosinsky Alexander Stuckey M. Tanguy Ana Lisa Taylor Tavares Ellen Thomas

10.1016/j.ajhg.2023.06.008 article EN cc-by The American Journal of Human Genetics 2023-07-07

The etiology of prostate cancer, the second most common cancer in men globally, has a strong heritable component. While rare coding germline variants several genes have been identified as risk factors from candidate gene and linkage studies, exome-wide spectrum causal remains to be fully explored. To more comprehensively address their contribution, we analysed data 37,184 cases 331,329 male controls five cohorts with exome/genome sequencing one cohort imputed array population enriched...

10.1101/2024.05.10.24307164 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-05-10

Abstract Macrophages play a pivotal role in anti-cancer immunity through phagocytosis and presentation of tumor antigens to T cells. Antibody-dependent cellular (ADCP), mediated by macrophages other myeloid cells, is key mechanism-of-action (MoA) for antibody-based cancer immunotherapies. Strategies that enhance ADCP macrophage effector functions not only promote direct destruction but also facilitate broader anti-tumor immunity. initiated the binding antibody Fc domains gamma receptors...

10.1158/1538-7445.am2025-2185 article EN Cancer Research 2025-04-21

Abstract Bispecific antibodies targeting immune checkpoints are transforming cancer immunotherapy by enabling novel mechanisms of action unattainable monospecific antibodies. These engineered molecules simultaneously engage two distinct epitopes, such as PD-1 and CTLA-4 or TIGIT, to amplify anti-tumor responses while minimizing off-target effects. Here we demonstrate the use cell-based reporter bioassays provide a robust platform for assessing functional potency, stability, specificity...

10.1158/1538-7445.am2025-7291 article EN Cancer Research 2025-04-21

Abstract The efficacy of immune checkpoint inhibitors (ICIs) is hampered by tumor-associated immunosuppressive myeloid cells. Secreted nano-sized (∼25-100 nm) bacterial extracellular vesicles (bEVs) modulate cells in the context infection and colonization, are being developed for cancer immunotherapy. However, lack standardized bEV purification strategies limit reproducibility across laboratories hamper translational development. Herein, we aimed to develop a scalable isolation workflow...

10.1158/1538-7445.am2025-961 article EN Cancer Research 2025-04-21

Sex differences in immune responses impact cancer outcomes and treatment response, including glioblastoma (GBM). However, host factors underlying sex specific immune-cancer interactions are poorly understood. Here, we identify the neurotransmitter γ-aminobutyric acid (GABA) as a driver of GBM-promoting response females. We demonstrated that GABA receptor B (GABBR) signaling enhances L-Arginine metabolism nitric oxide synthase 2 (NOS2) expression female granulocytic myeloid-derived suppressor...

10.1101/2024.07.18.603996 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2024-07-22

<title>Abstract</title> Sex differences in immune responses impact cancer outcomes and treatment response, including glioblastoma (GBM). However, host factors underlying sex specific immune-cancer interactions are poorly understood. Here, we identify the neurotransmitter γ-aminobutyric acid (GABA) as a driver of GBM-promoting response females. We demonstrated that GABA receptor B (GABBR) signaling enhances L-Arginine metabolism nitric oxide synthase 2 (NOS2) expression female granulocytic...

10.21203/rs.3.rs-4790899/v1 preprint EN cc-by Research Square (Research Square) 2024-08-05

<h3>Background</h3> Immune system primary effector cells, such as macrophage and natural killer are crucial in combating cancer through mechanisms antibody-dependent cellular phagocytosis (ADCP) cytotoxicity (ADCC). Both ADCP ADCC key antibody-based immunotherapies, beginning when antibodies bind to Fc gamma receptors (FcγRs) on the immune triggering a cascade of events that lead downstream response. <h3>Methods</h3> We have developed stable luminescent plate-based reporter bioassays measure...

10.1136/jitc-2024-sitc2024.1107 article EN cc-by-nc Regular and Young Investigator Award Abstracts 2024-11-01

Abstract Astrocytes are the most abundant glial cell in brain and have been shown to adopt reactive phenotypes upon interaction with glioma cells. While tumor-associated astrocyte (TAA) reactivity is linked increased inflammation, proliferation, invasion, treatment resistance of glioblastoma (GBM), mechanisms by which cancer cells reprogram TAA poorly defined. We previously that mitochondrial transfer from astrocytes GBM via GAP43-dependent microtubes alters cellular metabolism increases...

10.1093/neuonc/noae165.1213 article EN Neuro-Oncology 2024-11-01

Introduction: There is no consensus as to the optimal SARS-CoV-2 vaccination sequence in solid organ transplant recipients (SOTRs). Anti-spike antibody response two-dose BNT162b2 mRNA vaccine series poor SOTRs, and it possible that higher-dose mRNA-1273 could improve immunogenicity suboptimal responders, who are at high risk for infection. Methods: We evaluated 114 SOTRs tested negative on an anti-spike assay after two doses of had a third dose (D3) either homologous or heterologous vaccine....

10.1097/01.tp.0000885208.48960.70 article EN Transplantation 2022-09-01

This work proposes a method for using any generator network as the foundation of an Energy-Based Model (EBM). Our formulation posits that observed images are sum unobserved latent variables passed through and residual random variable spans gap between output image manifold. One can then define EBM includes part its forward pass, which we call Hat EBM. The model be trained without inferring data or calculating Jacobian determinant. enables explicit probabilistic modeling distribution type...

10.48550/arxiv.2210.16486 preprint EN cc-by arXiv (Cornell University) 2022-01-01

An abstract is not available for this content. As you have access to content, full HTML content provided on page. A PDF of also in through the ‘Save PDF’ action button.

10.1192/bjp.198.3.240 article EN The British Journal of Psychiatry 2011-03-01

Abstract Macrophages play a key role in the elimination of cancer via phagocytosis and presentation tumor antigens to T cells. Antibody-dependent cellular (ADCP), mediated by macrophages other myeloid cells, is an important mechanism-of-action (MoA) for antibody-based immunotherapies. Therapeutic strategies that enhance ADCP macrophage effector functions can augment direct destruction enable anti-tumor immunity. initiated binding antibody Fc domains gamma receptors (FcgRs), FcgR crosslinking...

10.1158/1538-7445.am2023-6370 article EN Cancer Research 2023-04-04

<h3>Background</h3> Antibody-dependent Cellular Phagocytosis (ADCP) is an important mechanism of action (MOA) therapeutic antibodies designed to deplete tumor cells. ADCP mediated by effector cells such as monocytes and macrophages, induced via simultaneous binding FcγRIIa, FcγRI, or FcγRIIIa on a specific antigen target Traditionally, direct measurement relies ex vivo differentiation primary macrophages followed flow cytometry assays. These protocols are laborious produce highly variable...

10.1136/jitc-2023-sitc2023.0978 article EN cc-by-nc Regular and Young Investigator Award Abstracts 2023-10-31

10.53841/bpsfu.2009.1.97.36 article EN Forensic Update 2009-01-01

We give a non-technical introduction to convergence-divergence models, new modeling approach for phylogenetic data that allows the usual divergence of species post speciation but also converge, i.e. become more similar over time. By examining $3$-taxon case in some detail we illustrate phylogeneticists have been "spoiled" sense not having think about structural parameters their models by virtue strong assumption evolution is treelike. show there are always good statistical reasons prefer...

10.48550/arxiv.1709.04548 preprint EN other-oa arXiv (Cornell University) 2017-01-01

We present a bottom-up approach for the task of object instance segmentation using single-shot model. The proposed model employs fully convolutional network which is trained to predict class-wise masks as well bounding boxes instances each pixel belongs. This allows us group pixels into individual instances. Our architecture based on DeepLabv3+ model, and requires only minimal extra computation achieve pixel-wise assignments. apply our method person segmentation, common relevant many...

10.48550/arxiv.1807.07674 preprint EN other-oa arXiv (Cornell University) 2018-01-01

This work presents strategies to learn an Energy-Based Model (EBM) according the desired length of its MCMC sampling trajectories. trajectories different lengths correspond models with purposes. Our experiments cover three trajectory magnitudes and learning outcomes: 1) shortrun for image generation; 2) midrun classifier-agnostic adversarial defense; 3) longrun principled modeling probability densities. To achieve these outcomes, we introduce novel methods initialization negative samples...

10.48550/arxiv.2205.12243 preprint EN cc-by arXiv (Cornell University) 2022-01-01
Coming Soon ...